You searched for N - Page 6 of 136

Critical Path for Rare Neurodegenerative Diseases

CP-RND was founded in September 2022 to lead collaborations that advance treatments to improve the lives of those affected by rare

Discover GEM-PD

Founded in 2008, the Critical Path for Alzheimer’s Disease (CPAD) enhances regulatory decision-making tools to advance drug deve

Critical Path for Alpha-1 Antitrypsin Deficiency CPA-1 is a public-private partnership comprised of industry partners, academic re

C-Path’s Biomarker Data Repository (BmDR) advances qualification of novel biomarkers as drug development tools. The initial pilo

July 22, 2025

Stakeholders across the life sciences ecosystem are invited to attend the 2025 C-Path's Global Impact Conference (CGIC), taking...

July 16, 2025

C-Path today announced the appointment of Aoife Brennan, M.D., to its Board of Directors. Dr. Brennan brings...

July 16, 2025

C-Path) Translational Therapeutics Accelerator (TRxA) proudly announced today a $200,000 grant to Carlos Subauste, M.D....

July 15, 2025

Critical Path Institute, which formed the T1D Consortium in 2017, is working to accelerate the process to new therapies...